Volver al Panel









Revvity, Inc. (RVTY)
Valores intradiarios en tiempo real
Resumen del Mercado
From:
To:
RVTY Intraday
No data available
SímboloRVTY
Fecha de SalidaFeb 21, 1973
CEODr. Prahlad R. Singh Ph.D.
Empleados a Tiempo Completo11k
SectorHealthcare
IndustriaDiagnostics & Research
PaísUnited States
BolsaNYSE
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, and training and services; and instruments, reagents, and assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. It also develops technologies that enable and support genomic workflows using protein coupled receptors and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Rendimiento
| Período | Rentabilidad % | Cambio de Valor |
|---|---|---|
| 1 Día | +0.87% | +1.37 US$ |
| 5 Días | +3.99% | +6.09 US$ |
| 1 Mes | +11.70% | +16.62 US$ |
| 6 Meses | +82.93% | +71.96 US$ |
Analizando el Mercado con IA
Evaluando los últimos 30 días de historial y métricas fundamentales de RVTY...
Estadísticas Clave
Cap. de Mercado
17.72B
Relación P/E
75.97
Rend. de Div.
0.18%
Máx. 52 Semanas
$166.25
Mín. 52 Semanas
$81.22
Consenso de Analistas
CONSENSOCompra
ALCISTA633.3%
NEUTRAL1161.1%
BAJISTA15.6%
Objetivos de Precios de Analistas a 52 Semanas
Objetivo Mín.
$110.00
$110.00
Objetivo Máx.
$175.00
$175.00
Actual$158.73
Objetivo Prom.$147.53
Recomendaciones de Analistas
Precio Objetivo:$147.53($110.00 - $175.00)
Pensamientos de la Comunidad
Comparta su análisis y sentimiento sobre RVTY
Únase a la comunidad para compartir su análisis
Últimas Noticias para RVTY

ELV vs. RVTY: Which Stock Is the Better Value Option?
Zacks•23 oct 2026, 14:40

Here's How IDEXX Laboratories Is Placed Ahead of Q3 Earnings
Zacks•23 oct 2026, 11:19

Revvity Launches Signals LabGistics to Coordinate Scientific Workflows
Zacks•22 oct 2026, 13:34

Align Technology to Report Q3 Earnings: What's in the Cards?
Zacks•22 oct 2026, 12:08

Labcorp Prepares to Report Q3 Earnings: What's in the Cards?
Zacks•21 oct 2026, 12:28

Revvity Launches Signals LabGistics Solution to Connect and Orchestrate Scientific Workflows
Business Wire•20 oct 2026, 12:00

1 Cash-Producing Stock to Own for Decades and 2 We Question
StockStory•16 oct 2026, 13:39
ETFs Are Net Sellers of Revvity (RVTY) on Wednesday
GuruFocus.com•16 oct 2026, 11:02

Revvity (RVTY), What Is Drawing Fresh Attention Now?
Simply Wall St.•15 oct 2026, 11:15

Revvity (RVTY) Stock Could Be 12% Stretched On Cash Flow
Simply Wall St.•15 oct 2026, 01:15